Xueming Wu Selected Research

cyclo(cysteinyl- glycyl- leucyl- isoleucyl- isoleucyl- glutaminyl- lysyl- asparaginyl- glutamyl- cysteinyl)

9/2013	MR molecular imaging of prostate cancer with a small molecular CLT1 peptide targeted contrast agent.
1/2013	Molecular MRI of atherosclerotic plaque progression in an ApoE(-/-) mouse model with a CLT1 peptide targeted macrocyclic Gd(III) chelate.
8/2012	Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.
4/2012	MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.
8/2010	An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix.
3/2010	Peptide-targeted Nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging.
12/2008	A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xueming Wu Research Topics

Disease

17	Neoplasms (Cancer) 01/2021 - 12/2008
4	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 04/2012
4	Breast Neoplasms (Breast Cancer) 10/2013 - 03/2010
2	Thrombosis (Thrombus) 01/2020 - 12/2018
2	Fibrosis (Cirrhosis) 12/2018 - 07/2016
2	Myocarditis (Carditis) 07/2016 - 06/2016
2	Retinal Degeneration 12/2014 - 01/2014
1	Microsatellite Instability 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Death (Near-Death Experience) 01/2020
1	Infarction (Infarctions) 12/2018
1	Myocardial Infarction 12/2018
1	Intervertebral Disc Degeneration 10/2017
1	Virus Diseases (Viral Diseases) 10/2017
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2016
1	Infections 06/2016
1	Stargardt Disease 12/2014
1	Macular Degeneration (Age-Related Maculopathy) 12/2014
1	Disease Progression 01/2013
1	Atherosclerotic Plaque (Atheroma) 01/2013
1	Atherosclerosis 01/2013
1	Eye Diseases (Eye Disease) 12/2011
1	Glioma (Gliomas) 05/2009
1	Carcinoma (Carcinomatosis) 12/2008

Drug/Important Bio-Agent (IBA)

15	Contrast MediaIBA 01/2016 - 12/2008
9	Peptides (Polypeptides)IBA 01/2014 - 12/2008
7	FibrinIBA 01/2014 - 12/2008
7	Fibronectins (Fibronectin)IBA 01/2014 - 12/2008
7	cyclo(cysteinyl- glycyl- leucyl- isoleucyl- isoleucyl- glutaminyl- lysyl- asparaginyl- glutamyl- cysteinyl)IBA 09/2013 - 12/2008
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2010
4	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 09/2013 - 03/2010
3	GadoliniumIBA 01/2016 - 08/2010
3	Proteins (Proteins, Gene)FDA Link 10/2013 - 08/2012
2	CollagenIBA 07/2016 - 06/2016
2	Blood Proteins (Serum Proteins)IBA 09/2013 - 08/2012
2	ManganeseIBA 03/2012 - 08/2010
2	CystamineIBA 02/2010 - 09/2009
2	Gadolinium DTPA (Magnevist)FDA Link 02/2010 - 09/2009
2	gadodiamide (Omniscan)FDA Link 09/2009 - 12/2008
1	musconeIBA 12/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018
1	Hypoxia-Inducible Factor 1IBA 12/2018
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 10/2017
1	AICA ribonucleotide (ZMP)IBA 06/2016
1	retinylamineIBA 12/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2014
1	Leucine (L-Leucine)FDA Link 12/2014
1	Phenylalanine (L-Phenylalanine)FDA Link 12/2014
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2014
1	Retinaldehyde (Retinal)IBA 12/2014
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2014
1	Dendrimers (Dendrons)IBA 01/2014
1	Schiff Bases (Schiff Base)IBA 01/2014
1	cysteinyl-arginyl-glutamyl-lysyl-alanylIBA 10/2013
1	gadoteridol (Prohance)FDA Link 10/2013
1	CholesterolIBA 01/2013
1	Apolipoproteins E (ApoE)IBA 01/2013
1	ApolipoproteinsIBA 01/2013
1	Pharmaceutical PreparationsIBA 12/2011
1	oncofetal fibronectinIBA 08/2010
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 08/2010
1	Bevacizumab (Avastin)FDA Link 02/2010
1	Cystine (L-Cystine)IBA 09/2009
1	albumin-(gadolinium-DTPA)IBA 09/2009
1	Small Interfering RNA (siRNA)IBA 05/2009

Therapy/Procedure

2	Stents 01/2020 - 12/2018
2	Therapeutics 07/2016 - 02/2010
1	Immunotherapy 01/2021
1	Oral Administration 12/2014
1	Intraperitoneal Injections 01/2014
1	Intravenous Injections 05/2009